01115nam a2200313 i 450099100064755970753620020507171730.0001211s1999 us ||| | eng 0817640444 (acid-free paper)b10737698-39ule_instLE01300130ExLDip.to Matematicaeng516AMS 00B15LC QA446.A28 Brylinski, Jean-Luc60174Advances in geometry /Jean-Luc Brylinski ... [et al.], editorsBoston ; Basel ; Berlin :Birkhauser,c1999ix, 399 p. ;25 cmProgress in mathematics [Birkhauser],ISSN 0743-1643;172Includes bibliographical referencesGeometryMathematical physics.b1073769823-02-1728-06-02991000647559707536LE013 00B BRY11 (1999)12013000124384le013-E0.00-l- 01010.i1082809628-06-02Advances in geometry911088UNISALENTOle01301-01-00ma -engus 0102356nas 2200673-a 450 99633590870331620240413024551.01744-8379(DE-599)ZDB2090846-5(CKB)111056648275076(CONSER)--2002243429(EXLCZ)9911105664827507620011114a20019999 --- -engtxtrdacontentcrdamediacrrdacarrierExpert review of pharmacoeconomics & outcomes researchLondon Future Drugs Ltd.[2001]-London :Informa HealthcareAbingdon, Oxford :Taylor & Francis1 online resourceRefereed/Peer-reviewedTitle from cover.Print version: Expert review of pharmacoeconomics & outcomes research. (DLC) 2002243429 (OCoLC)50638419 1473-7167 EXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCHEXPERT REV PHARMACOECON OUTCOMES RESEXPERT REV. PHARMACOECON. OUTCOMES RESEXPERT REV PHARM OUTExpert rev. pharmacoecon. outcomes res.DrugsCostsPeriodicalsChemotherapyEconomic aspectsPharmacologyEconomic aspectsPeriodicalsEconomics, PharmaceuticalCost-Benefit AnalysisDecision MakingDrug TherapyeconomicsOutcome Assessment, Health CareChemotherapyEconomic aspectsfast(OCoLC)fst00853599DrugsCostsfast(OCoLC)fst00898787Periodical.Review.Periodicals.fastPeriodicals.lcgftDrugsCostsChemotherapyEconomic aspects.PharmacologyEconomic aspectsEconomics, Pharmaceutical.Cost-Benefit Analysis.Decision Making.Drug Therapyeconomics.Outcome Assessment, Health Care.ChemotherapyEconomic aspects.DrugsCosts.JOURNAL996335908703316exl_impl conversionExpert review of pharmacoeconomics & outcomes research2381170UNISA